Antithymocyte Globulin Induced Recurrent Seizures in a Case of Severe Aplastic Anemia

被引：0
作者：
Sanjeev Kumar Sharma
Pawan Kumar Singh
Tulika Seth
Pravas Mishra
Manoranjan Mahapatra
机构：
[1] All India Institute of Medical Sciences,Department of Hematology
来源：
Indian Journal of Hematology and Blood Transfusion | 2014年 / 30卷
关键词：
Aplastic anemia; Antithymocyte globulin; Seizures;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Antithymocyte globulin (ATG) has been the standard immuno suppressive therapy for aplastic anemia. ATG significantly improves survival and response rates vary between 40 and 70 %. Mild side effects are common but recurrent seizures have rarely been reported with ATG.
引用
收藏
页码：70 / 71
页数：1
相关论文
共 47 条
  • [1] Camitta B(1983)Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia Blood 62 883-888
  • [2] O’Reilly RJ(1984)Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody Prog Clin Biol Res 148 227-238
  • [3] Sensenbrenner L(2003)Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome Blood 101 2156-2158
  • [4] Rappeport J(2005)Favourable response to antithymocyte globulin therapy in resistant acute graft-versus-host disease Bone Marrow Transpl 36 459-346
  • [5] Champlin R(1999)Cyclosporine neurotoxicity: a review J Neurol 246 339-326
  • [6] Doney K(2000)Neurotoxicity of calcineurin inhibitors: impact and clinical management Transpl Int 13 313-284
  • [7] Champlin R(1989)Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia Br J Haematol 72 278-242
  • [8] Ho W(1987)Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids and androgens Exp Hematol 15 239-276
  • [9] Bayever E(2000)Cyclosporine induces epileptiform activity in an in vitro seizure model Epilepsia 41 271-902
  • [10] Winston DJ(1995)Corticosteroids enhance convulsion susceptibility via central mineralocorticoid receptors Psychoneuroendocrinology 20 891-153
12345